Tasly Pharmaceutical Group Co., Ltd (SHA:600535)
China · Delayed Price · Currency is CNY 14.20
+0.19 (1.36%)
Oct 9, 2026, 3:00 PM CST
SHA:600535 Market Cap
SHA:600535 has a market cap or net worth of 21.21 billion as of October 9, 2026. It is the 5,026th most valuable company in the world and the 813th biggest in China. Its market cap has decreased by 10.13% in one year.
Market Cap
21.21B
Enterprise Value
17.88B
Revenue
8.15B
Global Rank
Country Rank
#813 China
PE Ratio
17.37
ChartMarket Cap Chart
Since November 3, 2004, SHA:600535's market cap has increased from 3.65B to 21.21B, an increase of 481.53%. That is a compound annual growth rate of 8.35%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 9, 2026 | 21.21B | -5.77% |
| Dec 31, 2025 | 22.51B | 4.22% |
| Dec 31, 2024 | 21.60B | -15.04% |
| Dec 29, 2023 | 25.43B | 59.04% |
| Dec 30, 2022 | 15.99B | -32.76% |
| Dec 31, 2021 | 23.78B | 6.62% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Tianjin Pharmaceutical Da Ren Tang Group Corporation | 23.64B |
| Livzon Pharmaceutical Group | 22.98B |
| Walvax Biotechnology | 22.52B |
| Jiangsu Nhwa Pharmaceutical Co., LTD | 22.19B |
| Hybio Pharmaceutical | 20.98B |
| Jilin Aodong Pharmaceutical Group | 20.24B |
| Betta Pharmaceuticals | 20.13B |
| Shanghai Haoyuan Chemexpress | 20.08B |